Lansen Pharmaceutical Holdings

Lansen Pharmaceutical Holdings is owned by Cathay International. Cathay International has a direct presence in 2 countries.

They are in:

• Holding50%
• Pharmaceuticals50%

View the org chart displaying its 11 main executives

Most searched biographies at Lansen Pharmaceutical Holdings

• Li Chen, Chief Executive Officer and Executive Managing Director
• Zhen Tao Wu, Non-Executive Chairman of the Board
• Ching Har Chan, Independent Non-Executive Director

Create your alert
to follow the executive moves at Lansen Pharmaceutical Holdings.

Cathay International has 1,859 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• MedMen has filed for bankruptcy protection  (posted on April 28 2024).
• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Danilo Cicmil - Supervisory Board Member at Galenika
• Emma Walmsley - Chief Executive Officer and Director at GSK

Learn more about the Pharmaceuticals industry >

Press releases by Lansen Pharmaceutical Holdings

• News
• News
• News

Social media about Lansen Pharmaceutical Holdings

• Lansen Pharmaceutical Holdings on Wikipedia, Google News & Yahoo Finance
• Lansen Pharmaceutical Holdings on LinkedIn, Twitter & YouTube

Contact by email its executives including Li Chen

Call Lansen Pharmaceutical Holdings at +86 574 ...

View the org chart

Register to receive your alert

Report an error